IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial. Ackerman L, Acloque G, Bacchelli S, Schwartz H, et al. Nat Med 2023;29:3127-3136.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ackerman L, Acloque G, Bacchelli S, Schwartz H, et al. IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial. Nat Med 2023;29:3127-3136.
PMID: 37957373